Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Methylpiperazine | HCID 66057 | — |
| Reactant | 1-Cyclopropyl-6,7-difluoro-5-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | HCID 14651254 | — |
| Solvent | N-methyl-2-pyrrolidone | HCID 13387 | — |
| Product | Grepafloxacin | HCID 72474 | 37.4% |
Reaction Steps
0.65 g of 2-methylpiperazine was added to a solution of 0.48 g of 1-cyclopropyl-6,7-difluoro-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid in 5 ml of N-methyl-2-pyrrolidone, followed by heating at 90° C. for 20 minutes. After distilling off the solvent under reduced pressure, the residue was added with ethanol. The resulting crystals were filtered and recrystallized from ethyl acetate-ethanol to give 231 mg of 1-cyclopropyl-6-fluoro-7-(3-methyl-1-piperazinyl)-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06333431B1 |
|---|
| Source dataset | uspto-grants-2001_12 |
|---|
| ORD ID | ord-0cf743d99f6147a3b5a4cbe9abea1817 |
|---|
| Source note | uspto-grants-2001_12 |
|---|